Bank of Montreal
NMTR

Bank of Montreal’s 9 Meters Biopharma NMTR Stock Holding History

Bank of Montreal’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,156
Closed -$19 – 4438
2022
Q3 		$19 Buy
4,156
+791
+24% +$3.92K ﹤0.01% 3811
2022
Q2 		$28 Buy
3,365
+355
+12% +$3.35K ﹤0.01% 3719
2022
Q1 		$36K Sell
3,010
-45
-1% -$614 ﹤0.01% 3841
2021
Q4 		$59K Sell
3,055
-118
-4% -$2.64K ﹤0.01% 3214
2021
Q3 		$86K Buy
3,173
+2,590
+444% +$61K ﹤0.01% 3481
2021
Q2 		$13K Buy
583
+13
+2% +$319 ﹤0.01% 3543
2021
Q1 		$14K Buy
570
+550
+2,750% +$16.9K ﹤0.01% 4216
2020
Q4 		$1K Buy
+20
New +$334 ﹤0.01% 4894
2019
Q3 		– Sell
-1,001
Closed -$23K – 5065
2019
Q2 		$23K Buy
1,001
+1
+0.1% +$30 ﹤0.01% 4109
2019
Q1 		$39K Sell
1,000
-15
-1% -$649 ﹤0.01% 3443
2018
Q4 		$47K Buy
1,015
+9
+0.9% +$667 ﹤0.01% 3302
2018
Q3 		$138K Buy
1,006
+999
+14,271% +$172K ﹤0.01% 2957
2018
Q2 		$3K Buy
+7
New +$2.58K ﹤0.01% 4285

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Bank of Montreal's NMTR Position: Q4 2022 in Review

Bank of Montreal sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 4,156 shares — an estimated $19 sold.

Bank of Montreal first reported a position in NMTR in Q2 2018 and held it in 13 quarters. The position peaked at $138K in Q3 2018. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • Bank of Montreal reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 4,156 9 Meters Biopharma shares in Q4 2022, an estimated $19.
  • Bank of Montreal first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 13 quarters.
  • Bank of Montreal's 9 Meters Biopharma position peaked at $138K in Q3 2018.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.